David Ilki Min, PharmD, MS, FCCP, FASHP
Professor of Pharmacy Practice and Administration
College of Pharmacy
1989 University of Minnesota
1987 University of MInnesota
Bachelor of Science in Pharmacy
1975 Seoul National University
1989 Research Fellowship
University of Minnesota Hospitals and Clinics, Minneapolis Minnesota
2 year Research Fellowship specialized in Organ Transplantation
St. Vincent Hospital
2131 W. Third Street
Los Angeles, CA 90057
My Research and Clinical Practice are in the area of kidney or kidney/pancreas transplantation pharmacotherapy. I am interested in achieving the optimal pharmacotherapy outcomes in these patient groups by pharmacokinetic, pharmacodynamic and pharmacogenomic research.
Yang JW, Hutchinson IV, Shah T, Min DI. Genetic and clinical risk factors of new-onset diabetes after transplantation in Hispanic kidney transplant recipients. Transplantation 2011;91:1114-1119
Shah T, Tellez-Corrales E, Yang JW, Wang J, Qazi Y, Wilson J, Hutchinson I, Min DI. The pharmacokinetics of enteric coated mycophenolate sodium and its gastrointestinal side effects in de novo renal transplant recipients of Hispanic ethnicity. Ther Drug Monit 2011;33:45-9.
Yang J, Hutchinson IV, Shah T, Min DI. Gene polymorphisms of vascular endothelial growth factor-A are associated with hypertensive nephropathy in a Hispanic population. Mol Biol Rep 2011;38:2419-2425.
Yang JW, Lee PH, Hutchinson I, Pravica V, Shah T, Min DI. Genetic polymorphisms of MRP2 and UGT2B7 and gastrointestinal symptom rating scale in renal transplant patients taking mycophenolic acid. Ther Drug Monit 2009;31(5):542-8.